WeChat

简体中文
 

Achievements

  • [Cell Biomaterials] Fully active zinc nitroprusside nanomedicine transforms cisplatin into chemoimmunotherapeutic agent for robust hepatocellular carcinoma therapy

    2026-01-22
  • [Nature Communications] Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years

    2026-01-16
  • [Science Translational Medicine] An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo

    2026-01-15
  • [Nature Communications] A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusion

    2025-12-18
  • [Nature Communications] Long-term protection from naturally acquired immunity against hepatitis E virus reinfection

    2025-12-17
  • [Gut] Engineered virus-hunter vaccine overcomes HBV immune tolerance

    2025-11-08
  • [eClinicalMedicine] Evaluation and optimization of mumps-containing vaccination strategies: a study based on an individual-based stochastic model

    2025-11-07
  • [Nature Biomedical Engineering] Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections

    2025-10-24
  • [Cancer Epidemiology, Biomarkers & Prevention]

    2025-10-09
  • [Advanced Science] Multimodal Imaging Reveals Cerebral Microcirculation Dynamics and Mechanisms in Mouse Central Nervous System after Intranasal Infection with Recombinant Pseudorabies Virus

    2025-09-25
    • FirstPrevious12345NextLast